Phosphorylation by protein kinases is recognized as a major mechanism by which virtually every activity of eukaryotic cells is regulated, including proliferation, gene expression, metabolism, motility, membrane transport, and apoptosis. An ultimate goal of research into signal transduction is to reach a full understanding of the protein phosphorylation events that occur within individual cell types and how they eventually impact on cell behavior. A milestone *en route*to this ambitious goal is a determination of the number of protein kinases encoded by eukaryotic genomes and an assessment of their structures, functions, and evolutionary relationships. This article traces the progress made toward achieving these objectives in the pregenomic and genomic eras, which culminated recently with reports on the \'full complement\' of human protein kinases.

The pregenomic era
==================

About sixteen years ago, while working at the Salk Institute, my colleagues and I undertook a comparative analysis of all the available sequences of protein kinase catalytic domains \[[@B1]\]. This interest stemmed from my having identified several novel human protein kinases using a homology-based cDNA cloning strategy \[[@B2]\] and wanting to determine their relationships to other known protein kinases. In collaboration with the Salk\'s resident protein kinase guru Tony Hunter and biocomputing specialist Anne Marie Quinn, we aligned the homologous catalytic-domain amino-acid sequences of 65 distinct protein kinases from diverse eukaryotes (including 45 nonorthologous vertebrate enzymes) and constructed a phylogenetic tree to visualize their overall relationships \[[@B1]\]. The alignment (produced manually at the word-processor) defined the boundaries of the eukaryotic protein kinase (ePK) catalytic domain, revealed conserved subdomains that were never interrupted by amino-acid insertions, and identified highly conserved individual amino acids and motifs (Figure [1](#F1){ref-type="fig"}).

The phylogenetic tree revealed major clusters including the tyrosine kinases (the TK group), cyclic nucleotide- and calcium-phospholipid-dependent kinases (the AGC group; including the PKA, PKG, and PKC families) and calmodulin-dependent kinases (the CAMK group). These groupings indicated that ePK domain phylogeny reflects substrate specificity and/or mode of regulation and could therefore serve as a useful classification tool. Over the next 7 years I continued to add new sequences to the alignment as they became available and to construct phylogenetic trees as a means of classifying the burgeoning ePK superfamily. By early 1994, the ePK domain alignment had grown to contain 390 sequences including 205 non-orthologous vertebrate ePKs, and a fourth major ePK group (CMGC, comprising the CDK, MAPK, GSK, and CLK families) had been added through phylogenetic analysis \[[@B3]\]. The 390 ePK domain alignment was made publicly available through the Protein Kinase Resource website \[[@B4]\].

The genomic era
===============

By 1995, with the advent of genome-sequencing projects, the task of cataloging and classifying the members of the ePK superfamily had grown to become too distracting from my funded research and I discontinued my efforts in this area. Tony Hunter continued to work with bioinformaticians at SUGEN, Inc. (including Greg Plowman, Gerard Manning, and Sucha Sudarsanam) to characterize the full ePK complements of model eukaryotes from genomic sequence data \[[@B5],[@B6]\]. By the time of a recent report \[[@B7]\], their efforts had resulted in the identification and classification of 115 distinct ePKs from budding yeast (around 2% of all genes), 434 from *Caenorhabditis elegans*(about 2.5% of all genes), and 223 from *Drosophila*. In addition they described the complement of \'atypical protein kinases\' (aPKs) from these species: 15 from yeast, 20 from *C. elegans*, and 16 from *Drosophila*. (The aPKs are a variety of protein kinases that lack strong sequence similarity to the classical ePK domain but have been shown experimentally to have protein kinase activity; well-known examples are the \'lipid kinases\' of the phosphatidylinositol 3\'-kinase (PI3K) family, some of which have been shown experimentally to have protein kinase activity.)

As a result of their comprehensive analyses of \'kinomes\', the SUGEN investigators were able to define three new major groups within the broad ePK classification scheme: first, the STE group, which includes ePKs that function in the MAPK kinase cascades that were first described through characterization of yeast *sterile*mutants; second, the CK1 group, including the casein kinase 1 family and related enzymes, which is greatly expanded in the worm; and third, the TKL (\'tyrosine-kinase like\') group that includes the STKR family of TGFbeta serine/threonine kinase receptors and is phylogenetically close to the tyrosine kinases (TKs). Many distinct kinase families within the AGC, CAMK, CMGC, STE, and CK1 groups have representatives from all three species, supporting the idea of an early evolutionary origin and critical function in basic cellular processes. Members of the TK and TKL groups are notably absent from yeast, consistent with the known functions of these ePKs in intercellular signaling events associated with metazoan complexity. More discussion of the evolutionary relationships among the ePKs identified through the SUGEN genome-mining efforts has been published elsewhere \[[@B7]\]. The SUGEN kinase.com website \[[@B8]\] includes links to all their published work on protein kinase analysis as well as \'KinBase\', a very useful searchable database that holds information on all the protein kinase genes found in the yeast, worm, fly, and human (see below) genomes.

Human protein kinases
---------------------

The completion of the first draft of the human genome sequence presented an opportunity to determine the full complement of human protein kinases. The first analysis came from a group led by Mitch Kostich at Schering-Plough Research Institute (SPRI) \[[@B9]\]. This group mined public GenBank records (available before December, 2001) for ePK sequences by performing BLAST searches using known ePK domains as queries. The resulting hits were consolidated, and efforts were made to remove non-human sequences, pseudogenes, and poor-quality sequences that could represent duplicate hits. The SPRI investigators chose to err on the side of inclusion rather than exclusion, however, and many cases of \'single hit\' sequences were retained. Their effort culminated in a collection of 510 potentially unique human ePKs. A color-coded alignment that accompanied their article \[[@B9]\] nicely illustrates the ePK domain sequence conservation.

The SUGEN group, led by Gerard Manning and Sucha Sudarsanam, carried out a more comprehensive effort to describe and classify all human ePKs \[[@B10]\]. They employed a dataset that included, in addition to the public databases, genomic reads from Celera that are not publicly available, non-public expressed sequence tags (ESTs) from Incyte and SUGEN, and they searched using a hidden Markov model of the ePK domain that allowed detection of very divergent family members. The sequence data were further searched for members of the various known aPK families. Using stringent criteria to eliminate false positives (including verification of novel sequences by cDNA cloning) they compiled a list of 478 human members of the ePK superfamily and another 40 aPKs, bringing their human kinome total to 518 (approximately 1.7% of all predicted human genes). They also identified 106 ePK or aPK pseudogenes.

A comparison of the SPRI-510 and SUGEN-518 lists reveals 474 protein kinases in common (see the additional file). Of the 44 SUGEN-specific kinases, 32 are aPKs; the other 8 aPKs identified by SUGEN, from the ABC1 and RIO families, were included in the SPRI list as a result of their having weak ePK domain similarity. Of the remaining 12 SUGEN-specific ePKs, five (TAK1, MLKL, NEK5, SgK307, and TBCK) were not available in the public data used in the SPRI analysis; another five (SgK196, SgK223, SgK424, SgK493, and Slob) have rather divergent ePK domains that lack many of the highly conserved residues and are unlikely to have catalytic activity, so it is easy to see how these might have been excluded by visual inspection; and the final two are SgK110 and NEK10. SgK110 was actually detected by the SPRI search, but it was erroneously merged with a related sequence AC008735_EPK1 (SgK069) on the same genomic contig; and it is unclear why the SPRI group missed NEK10. Most, if not all, of the 36 SPRI-specific ePKs represent over-inclusion errors (Table [1](#T1){ref-type="table"}): 14 correspond to sequences determined to be pseudogenes by the SUGEN group; 19 are based on single sequences that are (or appear to be) either poor-quality duplicates of other ePKs or interspecies contaminants; and the remaining three are duplicates arising by virtue of non-overlapping partial sequences.

Thus the SUGEN compilation of 478 human ePK superfamily genes represents the accurate count based on current sequence data. If one subtracts those that lack key conserved residues, we are left with 428 human ePKs with known or likely kinase function (Table [2](#T2){ref-type="table"}), 99% of which were included in the SPRI list; 365 of these fall within the seven major ePK groups: TK, 84 in total; CAMK, 66; AGC, 61; CMGC, 61; STE, 45; TKL, 37; and CK1, 11. The remaining 63 are in the \'Other\' category, falling outside the main ePK group branches. Krupa and Srinivasan \[[@B11]\] have also recently searched the public human genome data with a focus on identifying functional protein kinases; their efforts resulted in a list of 448 distinct human ePK sequences, but around 90 of these appear to represent duplicate entries, and no novel protein kinases were identified that were not present in the SUGEN compilation.

Usefulness of the kinome data
-----------------------------

Knowing the full complement of ePK family members and functional ePKs encoded by eukaryotic genomes will have great impact upon many areas of scientific investigation. As mentioned above, an obvious benefit relates to understanding of how signal transduction pathways evolved during the course of eukaryotic evolution. Both SUGEN \[[@B10]\] and Krupa and Srinivasan \[[@B11]\] extended their analyses to describe other domains present in the various human ePKs which are likely to function in directing the enzymes to relevant substrates or modulating kinase activities. Further analysis of the ePK domain sequences uniquely conserved within the major groups and families, together with comparisons of ePK domain crystal structures, should ultimately allow a full understanding of how different classes of peptide substrate are recognized. For example, Figure [2](#F2){ref-type="fig"} shows consensus sequences for the catalytic loop region in subdomain VIB (which includes the invariant aspartate thought to function as the catalytic base) and the activation loop region in subdomain VIII (which includes the highly conserved glutamine in the \'APE\' motif) - two regions that have been recognized as being primarily involved in peptide-substrate recognition \[[@B12],[@B13]\]. A number of group-specific differences are apparent (highlighted in Figure [2](#F2){ref-type="fig"}) that correlate with unique peptide-recognition tendencies for the ePKs that fall within a given group \[[@B14]\]. Beyond sequence analysis, the kinome data will allow for the development of comprehensive tools (such as full-length cDNAs, microarrays, antibodies, and fusion protein and RNAi constructs) that will greatly aid laboratory investigations aimed at understanding cell signaling through analysis of kinase function. As an example of such proteomic approaches to the study of protein kinases, nearly all yeast protein kinases have been expressed in bacteria and analyzed for their ability to phosphorylate an array of protein or peptide substrates using protein-chip technology \[[@B15]\]. Finally, the human kinome data will have benefits in the understanding and treatment of human diseases. The ePK genes that map within disease loci are attractive etiological candidates, and knowledge of the full repertoire of human protein kinases will greatly aid in the development of drugs that target specific protein kinases or protein kinase families whose function contributes to disease-associated cellular defects.

Additional data file
====================

An [additional data file](#s1){ref-type="supplementary-material"} with the 474 protein kinases in common between the SPRI-510 and the SUGEN-518 lists is available.
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Figures and Tables
==================

![The ePK catalytic domain. The 12 conserved subdomains are indicated by Roman numerals. The positions of amino-acid residues and motifs highly conserved throughout the ePK superfamily are indicated above the subdomains, using the single-letter amino-acid code with x as any amino acid. Crystal structures show that ePK domains adopt a common fold consisting of amino-terminal and carboxy-terminal lobes connected by a hinge region. Binding of Mg-ATP is largely the function of the amino-terminal lobe and hinge region, while peptide-substrate binding is mediated by the carboxy-terminal lobe. Particularly important for catalytic function are the invariant lysine in subdomain II and the invariant aspartate in subdomain VII that function to anchor and orient ATP, and the invariant aspartate in subdomain VIB which is the likely catalytic base in the phosphotransfer reaction. More detailed discussions of ePK subdomains and conserved residues in relation to crystal structures and catalytic function can be found in \[[@B3],[@B4],[@B12],[@B13]\].](gb-2003-4-5-111-1){#F1}

![Conserved residues implicated in peptide-substrate recognition. Consensus motifs for the catalytic loop region in subdomain VIB and activation loop region in subdomain VIII were determined for the members of each of the seven major ePK groups with known or likely kinase activity. Invariant residues at a given position are indicated by single upper-case letters. Two upper-case letters at a single position indicate that either of two residues are strictly conserved, the most frequent shown in the top row. Positions in which more than two amino acids are present are indicated with lower-case letters; a single letter indicates that only one residue is highly conserved, two letters indicate that either of two residues are frequently conserved (most frequent on the top row), and \'x\' indicating poor positional conservation. Residues highlighted in outline are notably conserved within an ePK group and are thought to function in the recognition of peptide substrates specifically targeted by the members of the group.](gb-2003-4-5-111-2){#F2}

###### 

Putative ePKs identified by SPRI but not SUGEN

  Category                                                  SPRI name       Comment                                                                
  --------------------------------------------------------- --------------- ---------------------------------------------------- -- -- -- -- -- -- --
  14 pseudogenes                                            LOC95530        Corresponds to SUGEN MAP2K2ps                                          
                                                            AC008014_EPK1   Corresponds to SUGEN MARKps22                                          
                                                            AC023095_EPK1   Corresponds to SUGEN PLK1ps1                                           
                                                            AC024933_EPK1   Corresponds to SUGEN MARKps30                                          
                                                            AC091554_EPK1   Corresponds to SUGEN SRPK2ps                                           
                                                            AI621045        Corresponds to SUGEN SgK384ps                                          
                                                            AI991174        Corresponds to SUGEN TSSKps2                                           
                                                            AL138964_EPK1   Corresponds to SUGEN MARKps23                                          
                                                            AL161450_EPK1   Corresponds to SUGEN CK1g2ps                                           
                                                            AL390061_EPK1   Corresponds to SUGEN MNK1ps                                            
                                                            BG742738        Corresponds to SUGEN TLK2ps2                                           
                                                            LOC65348        Corresponds to SUGEN CDK7ps                                            
                                                            LOC65743        Corresponds to SUGEN PAK2ps                                            
                                                            LOC85643        Corresponds to SUGEN CLK2ps                                            
                                                                                                                                                   
                                                                                                                                                   
                                                                                                                                                   
  11 duplicates from poor-quality single-EST sequences      AI342911        Corresponds to SUGEN CLK3                                              
                                                            AA565761        Corresponds to SUGEN CLK3                                              
                                                            AI826899        Corresponds to SUGEN CDK4                                              
                                                            AW148845        Corresponds to SUGEN ILK                                               
                                                            AW674733        Corresponds to SUGEN ILK                                               
                                                            AA730234        Corresponds to SUGEN MAP2K7                                            
                                                            AI075923        Corresponds to SUGEN TSSK4                                             
                                                            AI206530        Corresponds to SUGEN TLK1                                              
                                                            AW518044        Corresponds to SUGEN MPSK1                                             
                                                            AL538014        Corresponds to SUGEN BRSK2                                             
                                                            BG986727        Corresponds to SUGEN Obscn                                             
                                                                                                                                                   
                                                                                                                                                   
  Four non-human sequences                                  AC025598        *Mus musculus*MAP2K6                                                   
                                                            AC026940_EPK1   *Mus musculus*CDK7                                                     
                                                            PKCETB          *Rattus norvegicus*PKCeta                                              
                                                            CAMKII          *Sus scrofa*sequence, subsequently recalled                            
                                                                                                                                                   
                                                                                                                                                   
  Three duplicates from non-overlapping partial sequences   AC023837_EPK1   Part of EphA6                                                          
                                                            AA263006        Part of HIPK1 (along with BE180036)                                    
                                                            BE567816        Part of YANK1 (along with BG036777)                                    
                                                                                                                                                   
                                                                                                                                                   
  Four others                                               AW499744        Single EST; does not seem to encode an ePK                             
                                                            AJ336398_EPK1   Single genomic sequence, possibly prokaryotic                          
                                                            AL512402_EPK1   Single genomic sequence, possibly nonhuman                             
                                                            ILK2            Possibly murine ILK; published as human \[[@B16]\]                     

###### 

The 428 human ePKs with known or likely kinase catalytic function

  Group       Number within group   Family         Number within family   Family members (SUGEN nomenclature)
  ----------- --------------------- -------------- ---------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **TK**      84                    Ack            2                      ACK, TNK1
                                    Abl            2                      ABL, ARG
                                    Csk            2                      CSK, CTK
                                    FAK            2                      FAK, PYK2
                                    Fer            2                      FER, FES
                                    JAK            4                      JAK1, JAK2, JAK3, TYK2
                                    Src            11                     BLK, BRK, FGR, FRK, FYN, HCK, LCK, LYN, SRC, SRM, YES
                                    Syk            2                      SYK, ZAP70
                                    Tec            5                      BMX, BTK, ITK, TEC, TXK
                                    Alk            2                      ALK, LTK
                                    Axl            3                      AXL, MER, TYRO3
                                    DDR            2                      DDR1, DDR2
                                    EGFR           3                      EGFR, HER2/ErbB2, HER4/ErbB4
                                    Eph            12                     EphA1, EphA2, EphA3, EphA4, EphA5, EphA6, EphA7, EphA8, EphB1, EphB2, EphB3, EphB4
                                    FGFR           4                      FGFR1, FGFR2, FGFR3, FGFR4
                                    InsR           3                      IGF1R, INSR, IRR
                                    Lmr            3                      LMR1, LMR2, LMR3
                                    Met            2                      MET, RON
                                    Musk           1                      MUSK
                                    PDGFR/VEGFR    8                      FLT3, FMS, KIT, PDGFRa, PDGFRb, FLT1, FLT4, KDR
                                    Ret            1                      RET
                                    Ror            2                      ROR1, ROR2
                                    Sev            1                      ROS
                                    Tie            2                      TIE1, TIE2
                                    Trk            3                      TRKA, TRKB, TRKC
                                                                          
                                                                          
  **AGC**     61                    PKA            5                      PKACa, PKACb, PKACg, PRKX, PRKY
                                    PKG            2                      PKG1, PKG2
                                    PKC            9                      PKCa, PKCb, PKCd, PKCe, PKCg, PKCh, PKCi, PKCt, PKCz
                                    AKT            3                      AKT1, AKT2, AKT3
                                    DMPK           7                      CRIK, DMPK1, DMPK2, MRCKa, MRCKb, ROCK1, ROCK2
                                    GRK            7                      BARK1, BARK2, GPRK4, GPRK5, GPRK6, GPRK7, RHOK
                                    MAST           5                      MAST1, MAST2, MAST3, MAST4, MASTL
                                    NDR            4                      LATS1, LATS2, NDR1, NDR2
                                    PKB            1                      PDK1
                                    PKN            3                      PKN1, PKN2, PKN3
                                    RSK            9                      MSK1, MSK2, RSK1, RSK2, RSK3, RSK4, SgK494, p70S6K, p70S6Kb
                                    SGK            3                      SGK, SGK2, SGK3
                                    YANK           3                      YANK1, YANK2, YANK3
                                                                          
                                                                          
  **CAMK**    66                    CAMK1          5                      CaMK1a, CaMK1b, CaMK1d, CaMK1g, CaMK4
                                    CAMK2          4                      CaMK2a, CaMK2b, CaMK2d, CaMK2g
                                    CAMKL          20                     AMPKa1, AMPKa2, BRSK1, BRSK2, CHK1, HUNK, LKB1, MARK1, MARK2, MARK3, MARK4, MEL, NIM1, NuaK1, NuaK2, PASK, QIK, QSK, SIK, SNRK
                                    DAPK           5                      DAPK1, DAPK2, DAPK3, DRAK1, DRAK2
                                    DCAMKL         3                      DCAMKL1, DCAMKL2, DCAMKL3
                                    MAPKAPK        5                      MAPKAPK2, MAPKAPK3, MAPKAPK5, MNK1, MNK2
                                    MLCK           4                      caMLCK, skMLCK, smMLCK, SgK085
                                    PHK            2                      PHKg1, PHKg2
                                    PIM            3                      PIM1, PIM2, PIM3
                                    PKD            3                      PKD1, PKD2, PKD3
                                    PSK            1                      PSKH1
                                    RAD53          1                      CHK2
                                    Trio           4                      Obscn, SPEG, Trad, Trio
                                    TSSK           5                      SSTK, TSSK1, TSSK2, TSSK3, TSSK
                                    CAMK-Unique    1                      STK33
                                                                          
                                                                          
  **CMGC**    61                    CDK            20                     CCRK, CDC2, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, CDK10, CDK11, CHED, CRK7, PCTAIRE1, PCTAIRE2, PCTAIRE3, PFTAIRE1, PFTAIRE2, PITSLRE
                                    MAPK           14                     Erk1, Erk2, Erk3, Erk4, Erk5, Erk7, JNK1, JNK2, JNK3, NLK, p38a, p38b, p38d, p38g
                                    GSK            2                      GSK3A, GSK3B
                                    CLK            4                      CLK1, CLK2, CLK3, CLK4
                                    CDKL           5                      CDKL1, CDKL2, CDKL3, CDKL4, CDKL5
                                    DYRK           10                     DYRK1A, DYRK1B, DYRK2, DYRK3, DYRK4, HIPK1, HIPK2, HIPK3, HIPK4, PRP4
                                    RCK            3                      ICK, MAK, MOK
                                    SRPK           3                      MSSK1, SRPK1, SRPK2
                                                                          
                                                                          
  **STE**     45                    STE7           7                      MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7
                                    STE20          28                     GCK, HPK1, KHS1, KHS2, LOK, MST1, MST2, MST3, MST4, MYO3A, MYO3B, OSR1, PAK1, PAK2, PAK3, PAK4, PAK5, PAK6, SLK, STLK3, TAO1, TAO2, TAO3, YSK1, ZC1/HGK, ZC2/TNIK, ZC3/MINK, ZC4/NRK
                                    STE11          8                      MAP3K1, MAP3K2, MAP3K3, MAP3K4, MAP3K5, MAP3K6, MAP3K7, MAP3K8
                                    STE-Unique     2                      COT, NIK
                                                                          
                                                                          
  **TKL**     37                    IRAK           2                      IRAK1, IRAK4
                                    LISK           4                      LIMK1, LIMK2, TESK1, TESK2
                                    LRRK           2                      LRRK1, LRRK2
                                    MLK            9                      DLK, HH498, LZK, MLK1, MLK2, MLK3, MLK4, TAK1, ZAK
                                    RAF            3                      ARAF, BRAF, RAF1
                                    RIPK           5                      ANKRD3, RIPK1, RIPK2, RIPK3, SgK288
                                    STKR           12                     ACTR2, ACTR2B, ALK1, ALK2, ALK4, ALK7, BMPR1A, BMPR1B, BMPR2, MISR2, TGFbR1, TGFbR2
                                                                          
                                                                          
  **CK1**     11                    CK1            7                      CK1a, CK1a2, CK1d, CK1e, CK1g1, CK1g2, CK1g3
                                    TTBK           2                      TTBK1, TTBK2
                                    VRK            2                      VRK1, VRK2
                                                                          
                                                                          
  **Other**   63                    Aur            3                      AurA, AurB, AurC
                                    BUB            1                      BUB1
                                    Bud32          1                      PRPK
                                    CAMKK          2                      CaMKK1, CaMKK2
                                    CDC7           1                      CDC7
                                    CK2            2                      CK2a1, CK2a2
                                    IKK            4                      IKKa, IKKb, IKKe, TBK1
                                    IRE            2                      IRE1, IRE2
                                    MOS            1                      MOS
                                    NAK            4                      AAK1, BIKE, GAK, MPSK1
                                    NEK            11                     NEK1, NEK2, NEK3, NEK4, NEK5, NEK6, NEK7, NEK8, NEK9, NEK10, NEK11
                                    NKF1           3                      SBK, SgK069, SgK110
                                    NKF2           1                      PINK1
                                    NKF4           2                      CLIK1, CLIK1L
                                    PEK            4                      GCN2, HRI, PEK, PKR
                                    PLK            4                      PLK1, PLK2, PLK3, PLK4
                                    TLK            2                      TLK1, TLK2
                                    TOPK           1                      PBK
                                    TTK            1                      TTK
                                    ULK            4                      Fused, ULK1, ULK2, ULK3
                                    VPS15          1                      PIK3R4
                                    WEE            3                      MYT1, Wee1, Wee1B
                                    Wnk            4                      Wnk1, Wnk2, Wnk3, Wnk4
                                    Other-Unique   2                      KIS, SgK496
